ALS vs. MS Amyotrophic lateral sclerosis and multiple sclerosis both affect the nervous system. They have many symptoms in common, including weakness and trouble walking. But these two conditions are different. MS is an autoimmune disease. The immune system attacks and damages myelin, the protective...
Multiple sclerosis vs. myasthenia gravis MS andmyasthenia gravis(MG) are both disorders of the immune system that cause weakness. MS impacts the central nervous system and more parts of the body, including vision, balance, and coordination. On the other hand, the primary symptom of MG is facia...
possible novel therapy for multiple sclerosis mult. scler. , 2 ( 4 ) ( 1996 ) , pp. 206 - 210 a. achiron , m. mandel t-cell vaccination in multiple sclerosis autoimmun. rev. , 3 ( 1 ) ( 2004 ) , pp. 25 - 32 a. achiron , e. pras , r. gilad , i. ziv , m. mandel...
(VS-101)VISUAL METHODOLOGY FOR EARLY DETECTION OF MULTIPLE SCLEROSIS AND OTHER DISEASESMultiple sclerosis (MS) is a progressive disease characterized by decreased neural function from scarring of myelin tissue. Standard tests reveal decrements in MS, but few disclose subtle visual changes which...
Depression and anxiety are commonly observed in people with multiple sclerosis (pwMS). There is a growing body of literature supporting the hypothesis that personality traits can influence the mood disorders. This study aimed to investigate the
Multiple sclerosis (MS) is thought to be an autoimmune disease; however, the exact cause is not known. Early signs and symptoms of MS are fatigue, bladder and bowel problems, vision problems, and numbness, tingling, or pain in certain areas of the body.
Multiple sclerosis (MS) is a neuro-inflammatory and neurodegenerative disease that is most prevalent in Northern Europe. Although it is known that inherited risk for MS is located within or in close proximity to immune-related genes, it is unknown when, where and how this genetic risk originated...
Multiple sclerosis (MS) is a demyelinating disease presumed to be of autoimmune etiology. The disease presents with neurologic deficits and generally has a relapsing course followed by a progressive phase. The disease is more common in females (2:1 vs. males), and there appears to be a geneti...
The cause of Multiple Sclerosis (MS) is not fully understood. Auto-reactive inflammatory cells including effector T cells (Th1, Th17, CD8+Cytotoxic T cells), activated B cells, and plasma cells producing autoantibodies infiltrate the central nervous system (CNS). This leads to patchy myelin and...
Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. Alemtuzumab, a humanized monoclonal antibody that targets CD52 on lymphocytes and monocytes, may be an effective treatment for early multiple sclerosis. In... D Bourdette,V Yadav - 《Current Neurology & Neuroscience Reports》 被引量:...